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Introduction
Gulf War Illness (GWI) is a multi-symptom disorder with features characteristic of "sickness" behavior including cognitive impairment, fatigue, depression, sleep disruption, and gastrointestinal and dermatological problems. Sickness behavior, a normal manifestation of an inflammatory response due to infection or injury, resolves when homeostasis is restored, but in GWI the symptoms persist, findings suggestive of a heightened or chronic neuroimmune/neuroinflammatory disorder. The expression of proinflammatory cytokines and chemokines are the basis of sickness behavior and are the key elements of inflammation. Notably, low level inhalation exposure of sarin in experimental animals, the nerve agent implicated in GWI, causes neuroinflammation; further, the sarin surrogate diisopropyl phosphorofluoridate (DFP) increases proinflammatory cytokine expression in multiple brain regions. Finally, the stress of the war theater may have affected the blood brain barrier, allowing GWI-relevant agents access to the CNS. A role for stress in GWI is bolstered by our finding of increased proinflammatory cytokine expression in brain when DFP is preceded by a week of treatment with the rodent-specific stress hormone, corticosterone (CORT). The above observations suggest a possible critical and unrecognized link between the stressful environment of the Gulf War (GW) theater, agent exposure(s) unique to this war, and a resulting adverse heightened neuroinflammatory outcome. Our overarching hypothesis is that exposure to GWI-relevant compounds leads to enhanced and/or prolonged expression of proinflammatory mediators in the brain. Our data also lead us to hypothesize that brief high physiological levels of the stress hormone, cortisol (CORTin the rodent), greatly exacerbate the neuroinflammatory effects of GWI-related exposures, and that the FDA-approved antiinflammatory, minocycline, can ameliorate heightened neuroinflammation. Thus, our overall objective is to establish a neuroinflammatory model of GWI-related exposures, to define the contribution of high physiological stress in the initiation, strength, and duration of the neuroinflammation observed, and to assess the potential for currently available pharmacotherapy to ameliorate these effects with the ultimate goal of treating veterans suffering from GWI.
Body
The accomplishments associated with the third year of the project are outlined below with linkage to each task in the detailed Statement of Work.
Timeline: Because work at the Centers for Disease Control and Prevention could not be initiated until establishment of the DOD-initiated and UIC-approved CRADA, funds were not available and work on the project did not commence until Oct. 1, 2010, the beginning of the fiscal year (after late July 2010 approval of the CRADA between UIC and CDC). Thus, the progress reported to date has occurred during the first 35 months of the project. In the 15 day post-CORT experiments we found that chronic CORT given in the drinking water for 7 days caused exacerbated and prolonged neuroinflammation after a single LPS administration 24 hours after the cessation of CORT treatment. We have found that this priming of the CNS neuroinflammatory response can last at least 30 days after LPS. In addition, after CORT treatment for 7 days mice were left untreated for 30 days and then given a single systemic dose of LPS. At 6 hours after LPS administration, the mice previously exposed to CORTin the drinking water for 7 days showed significantly higher expression of proinflammatory cytokines and chemokines in the hippocampus (figure 1} and cortex (figure 2). This CORT priming effect was no longer present when mice were left untreated for 180 days (figure 3}.
Another group of mice were dosed with CORT in the drinking water for 1 week out of each month for 180 days. At 6 h after LPS administration on day 180 the repeated intermittent CORT regimen caused significant exacerbation of LPS-induced neuroinflammation (figure 3). The degree to which this CORT dosing regimen exacerbated the expression of proinflammatory cytokines and chemokines is in some cases more than 1000 fold over that seen at the 15 day time point.
Task 8. Determine the functional consequences of exposure to GWI-Relevant Agents (Meets Aims 1-3) Efforts to provide functional correlates to the neuroinflammation resulting from various combinations of chronic CORT and inflammagen cholinesterase inhibitors through the implementation of synaptic plasticity paradigms are ongoing at the University of Illinois College of Medicine using the mouse model and recording in anesthetized intact animals. Input-output (1/0) curves are evaluated in each animal along with paired-pulse functions and induction of hippocampal long term potentiation (LTP)-an electrophysiological correlate of learning/memory. These assessments are performed in CORT-treated mice 15 or 90 days after challenge with DFP or LPS to determine whether neuronal excitability parallels the neuroinflammatory changes that are occurring. LTP from mice treated in the same way but also given minocycline are being evaluated as well. Mice treated with CORT, PB & DEET and challenged with LPS or DFP are being evaluated with experimental parameters mirroring those employed in studies to fulfill Tasks 5 & 6. This work is ongoing, but there are no completed group results to present at this time.
Task 9. Disseminate information. Some of these findings were summarized in abstract form and presented at the Annual Meeting for the Society of Toxicology in San Antonio, TX in March,
2013.
More recent work has been summarized in abstract form and will be presented at the Annual Meeting for the Society for Neuroscience in San Diego, CA in November 2013. 
Key Research Accomplishments

1.
Demonstration that prior administration of high physiological stress levels of CORT augment the neuroinflammatory effect of LPS out to 30 days after cessation of CORT treatment. That is, the CORT priming effect on LPS-induced neuroinflammation endures for at least a few weeks. 2. Demonstration that repeated intermittent exposures to high physiological stress levels of CORT have a cumulative effect on the CNS neuroinflammatory response. That is, multiple chronic exposures to CORT appear to have a potentiating effect on LPS-induced neuroinflammation. 
Reportable Outcomes
Conclusions to date:
Our findings are suggestive of a possible critical and as yet unrecognized interaction between the stressful environs of the GW theater and agent exposure(s) unique to this war, exposures in which the CNS is primed by stress to amplify future exposures to pathogens, injury or toxicity. Such occurrences could potentially result in prolonged episodes of sickness behavior similar to those of GWI. We have shown that chronic exposure to the glucocorticoid, corticosterone (CORT), at levels associated with high physiological stress, can prime the CNS proinflammatory response to neurotoxic exposures and systemic inflammation. Such neuroinflammatory events can be associated with sickness behavior. Gulf War (GW) Illness is a multi-symptom disorder with features characteristic of persistent sickness behavior. GW veterans were exposed to the stresses of war, prophylactic treatment with the reversible acetylcholinesterase (AChE) inhibitor pyridostigmine bromide (PB), the insect repellent DEET and, potentially, the nerve agent, sarin. These combined exposures were designed to mimic the conditions existing in theater during the 1991 GW. Here we examined whether CORT exposures primed the CNS to mount neuroinflammatory responses to GW exposures. Male C57BL/6 mice were treated with chronic (14 days) PB (2 mglkg/day, s.c.) and DEET (30 mg/kg/day, s.c.); as well as subchronic exposure to CORT (200 ~g/ml in the drinking water on days 7-14) followed by acute exposure (day 15) to the sarin surrogate and irreversible AChE inhibitor, diisopropyl phosphorofluoridate; (DFP) (4 mg/kg, i.p.) or known inflammogen, lipopolysaccharide (LPS) ( 2 mg/kg, s.c.). We found that DFP alone, as well as LPS alone, caused a marked neuroinflammation as assessed by qRT-PCR ofiL1~, TNFa, IL6, CCL2, LIF and OSM. Chronic pretreatment with high physiological levels ofCORT and/or PB and DEET greatly augmented (up to 500-fold) the neuroinflammatory response to LPS and DFP in hippocampus, cortex and striatum. Our findings are suggestive of a possible critical and as yet unrecognized interaction between the stressful environs of the GW theater and agent exposure(s) unique to this war, exposures in which the CNS is primed to amplify future exposures to pathogens, injury or toxicity. Such occurrences could potentially result in prolonged episodes of sickness behavior. We have shown previously that chronic exposure to the glucocorticoid corticosterone, (CORT), at levels associated with high physiological stress, can prime the CNS proinflammatory response to neurotoxic insults. Persistent sickness behavior, a prominent component of Gulf War (GW) Illness, is associated with neuroinflammation. Veterans of the 1991 GW were exposed to the stresses of war, prophylactic treatment with the reversible acetylcholinesterase (AChE) inhibitor, pyridostigmine bromide (PB), the insect repellent, DEET, and, potentially, acutely to the nerve agent sarin. Previously, we showed that subchronic CORT pretreatment primed the CNS to mount a neuroinflammatory response to these GW exposures when provoked 24 h after the termination of CORT treatment. Here, we investigated the persistence of this priming effect on neuroinflammation and the minimal amount of CORT required to produce the priming response. Male C57BL/6 mice were pretreated with chronic (14 days) PB (2mg/kg/day, s.c.) and DEET (30 mg/kg/day, s.c.), as well as subchronic CORT (200 Jlg/ml in drinking water on days 7-14) or acute CORT (20 mg/kg, s.c., 2 injections, 7 h interval on day 14) exposures. Acute doses (days 15 or 45) of the sarin surrogate and irreversible AChE inhibitor diisopropyl phophorofluoridate (DFP, 4 mg/kg, i.p.) or known inflammogen lipopolysaccharide (LPS, 2 mg/kg, s.c.) were used to provoke neuroinflammation. We found that both acute and chronic CORT exposure greatly augmented neuroinflammation in response to LPS and DFP. Marked neuroinflammation in response to DFP was found even when the exposure was 30 days after the cessation of the subchronic CORT treatment (a time point equivalent to 6 years in humans). Our findings are suggestive of a possible critical and yet unrecognized link between the stressful environs of the 1991 GW theater and agent exposure(s) unique to this war, exposures in which the CNS is primed to amplify future exposure to pathogens, injury or toxicity. (Supported by CDMRP W81XWH-09-2-0098)
